Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
Authors: Pillai, Jagan A.1,2,3,4 (AUTHOR) pillaij@ccf.org, Bena, James5 (AUTHOR), Bekris, Lynn4,6 (AUTHOR), Kodur, Nandan4 (AUTHOR), Kasumov, Takhar7 (AUTHOR), Leverenz, James B.1,2,3,4 (AUTHOR), Kashyap, Sangeeta R.4,8 (AUTHOR)
Source: Alzheimer's Research & Therapy. 3/16/2023, Vol. 15 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17589193
DOI:10.1186/s13195-023-01203-y